[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"LeMaitre Vascular\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":61},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100468942","a-pmcf-study-confirm-the-performance-and-safety-of-the-tuftex-over-the-wire-otw-embolectomy-catheters-100468942",false,"NCT05386342","A PMCF Study Confirm the Performance and Safety of the TufTex Over-the-Wire (OTW) Embolectomy Catheters","A Post-market Clinical Study to Confirm the Performance and Safety of the LeMaitre TufTex Over-the-Wire (OTW) Embolectomy Catheter on Patients Undergoing Surgical Treatment for the Removal of Arterial Emboli and\u002For Thrombi","OTW","Inclusion Criteria:\n\n1. Male and female subject, ≥ 18 years of age at time of enrollment.\n2. Subject who is scheduled to undergo surgical treatment for the removal of an emboli or thrombi during an embolectomy and\u002For thrombectomy procedure, where one of the LeMaitre® Embolectomy Catheter will be used.\n3. Subject signed an Informed Consent for participation.\n4. Subject diagnosed with a embolus\u002Fthrombus.\n5. Subjects for whom thrombolytic therapy had failed or was contraindicated.\n\nExclusion Criteria:\n\n1. Co-morbidity that in the discretion of the investigator might confound the results.\n2. Subjects who are unable to read or write.\n3. Pregnant or lactating women at time of enrollment\n4. Subjects who are immune compromised","ALL","18 Years",{"count":20,"type":21},112,"ESTIMATED","INTERVENTIONAL",[24],"NA","A PMCF study to confirm the performance and safety of the LeMaitre® TufTex Over-the-Wire Embolectomy Catheter",[27,28,29],"Thrombus","Embolus","Occlusion; Vessel","RECRUITING","2024-10-16",{"date":33,"type":34},"2024-10-18","ACTUAL",{"date":36,"type":34},"2023-01-11",{"date":38,"type":21},"2027-06",{"name":40,"class":41},"LeMaitre Vascular","INDUSTRY",3,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":52,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":56,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":60,"locationsCount":42},"100468937","a-pmcf-study-to-confirm-the-performance-and-safety-of-the-lemaitre-tuftex-single-lumen-embolectomy-catheter-100468937","NCT05386277","A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter","A Post Market Clinical Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on Patients Undergoing Surgical Treatment for the Removal of Arterial Emboli and\u002For Thrombi","SLC","Inclusion Criteria:\n\n1. Male and female subject, ≥ 18 years of age at time of enrollment.\n2. Subject who is scheduled to undergo surgical treatment for the removal of arterial or venous emboli and\u002For thrombi, where one of the LeMaitre® Embolectomy Catheter will be used.\n3. Subject signed an Informed Consent for participation.\n4. Subject diagnosed with a embolus\u002Fthrombus.\n5. Subjects for whom thrombolytic therapy had failed or was contraindicated.\n\nExclusion Criteria:\n\n1. Co-morbidity that in the discretion of the investigator might confound the results.\n2. Subjects who are unable to read or write.\n3. Pregnant or lactating women at time of enrollment\n4. Subjects who are immune comprised",{"count":20,"type":21},[24],"A post market clinical study to confirm the performance and safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter on patients undergoing surgical treatment for the removal of arterial emboli and\u002For thrombi",[55],"Arterial Thromboembolism",{"date":33,"type":34},{"date":58,"type":34},"2022-01-11",{"date":38,"type":21},{"name":40,"class":41},""]